Experts examine the reasoning behind a steep rise in tick-borne illnesses, such as Lyme disease, in the United States and discuss the best ways to thwart this serious public health threat.
Researchers evaluated first-line treatment with arthemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria infection living in areas with an increased prevalence of multidrug-resistant parasites.
Researchers from the Centers for Disease Control and Prevention assessed the use of nifurtimox for the treatment of patients with American trypanosomiasis (Chagas disease).
Researchers conducted a retrospective review that evaluated the field effectiveness of tick-borne encephalitis vaccination across all patient age groups.
Researchers conducted a study among healthy adults that investigated the pharmacokinetic profile, safety, and tolerability of triaminopyrimidine ZY-19480, a novel antimalarial agent.
Investigators conducted a study that compared the safety and effectiveness of oral fexinidazole with nifurtimox-eflornithine combination therapy for the treatment of stage II gambiense human African trypanosomiasis.
A team of researchers investigated whether credible evidence supporting a causal relationship between Lyme disease and Alzheimer disease or Lewy body dementia exists.
Researchers conducted a study to determine whether audio dramas delivered via WhatsApp are effective for decreasing the belief in highly prevalent health misinformation among individuals in Sierra Leone.
Researchers conducted a study to determine whether the TAK-003 vaccine effectively protects against dengue fever in children and adolescents for up to 3 years.
Investigators conducted sought to determine the efficacy of artemether-lumefantrine against Plasmodium falciparum and if treatment outcomes are linked to genetic traits in the Pfkelch13 alleles.
Study authors searched medical databases to identify factors that could be detected in the febrile phase associated with progression to severe dengue disease.
Researchers used a retrospective survey to associate sexual behavior during the Zika virus epidemic to better understand the disease burden of sexually transmitted Zika virus.
TicoVac is an inactivated whole virus vaccine developed using a master ‘seed’ virus that is similar to the tick-borne encephalitis virus found in nature.
Quantitative MRI with brain volume assessment and ADC histogram analyses were performed for the first time in 65 patients with cerebral malaria to compare disease signatures of children and adults as well as fatal and nonfatal cases.
